{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:51:34Z","timestamp":1792461094522,"version":"4.5.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","derm.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.det.2015.03.018","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T03:53:57Z","timestamp":1435809237000},"page":"579-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":258,"title":["New World and Old World Leishmania Infections"],"prefix":"10.1016","volume":"33","author":[{"given":"Ines","family":"Kevric","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Cappel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.det.2015.03.018_bib1","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1469-0691.2011.03635.x","article-title":"Leishmaniasis impact and treatment access","volume":"17","author":"den Boer","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.det.2015.03.018_bib2","unstructured":"Leishmaniasis. 2014. Available at: http:\/\/www.who.int\/topics\/leishmaniasis\/en\/. Accessed April 02, 2014."},{"key":"10.1016\/j.det.2015.03.018_bib3","unstructured":"Parasites. Leishmaniasis. 2013. Available at: http:\/\/www.cdc.gov\/parasites\/leishmaniasis\/index.html. Accessed April 02, 2014."},{"issue":"1","key":"10.1016\/j.det.2015.03.018_bib4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1128\/CMR.17.1.136-173.2004","article-title":"Global change and human vulnerability to vector-borne diseases","volume":"17","author":"Sutherst","year":"2004","journal-title":"Clin Microbiol Rev"},{"issue":"12","key":"10.1016\/j.det.2015.03.018_bib5","doi-asserted-by":"crossref","first-page":"e1032","DOI":"10.1016\/j.ijid.2010.06.019","article-title":"Leishmaniasis, an emerging infection in travelers","volume":"14","author":"Pavli","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"12","key":"10.1016\/j.det.2015.03.018_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/qjmed\/hch127","article-title":"New World mucosal and cutaneous leishmaniasis: an emerging health problem among British travellers","volume":"97","author":"Lawn","year":"2004","journal-title":"QJM"},{"issue":"2","key":"10.1016\/j.det.2015.03.018_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-4632.2004.01991.x","article-title":"Localized cutaneous leishmaniasis imported into Paris: a review of 39 cases","volume":"43","author":"El Hajj","year":"2004","journal-title":"Int J Dermatol"},{"issue":"8","key":"10.1016\/j.det.2015.03.018_bib8","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3201\/eid1708.050486","article-title":"Changing pattern of visceral leishmaniasis, United Kingdom, 1985-2004","volume":"12","author":"Malik","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.det.2015.03.018_bib9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaad.2007.11.008","article-title":"Cutaneous leishmaniasis in Texas: a northern spread of endemic areas","volume":"58","author":"Wright","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2015.03.018_bib10","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/clind\/15.6.924","article-title":"Cutaneous leishmaniasis: review of 59 cases seen at the National Institutes of Health","volume":"15","author":"Melby","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.det.2015.03.018_bib11","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10096-005-1363-1","article-title":"Imported leishmaniasis in Germany 2001-2004: data of the SIMPID surveillance network","volume":"24","author":"Weitzel","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"10.1016\/j.det.2015.03.018_bib12","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1537-2995.2006.00941.x","article-title":"Leishmania: risk to the blood supply","volume":"46","author":"Cardo","year":"2006","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.det.2015.03.018_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/1064744042000210384","article-title":"Visceral leishmaniasis (kala-azar) and pregnancy","volume":"12","author":"Figueiro-Filho","year":"2004","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.det.2015.03.018_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-4632.2007.03154.x","article-title":"Clinical manifestations and classification of Old World cutaneous leishmaniasis","volume":"46","author":"Akilov","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2015.03.018_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(06)64001-3","article-title":"Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans","volume":"64","author":"Banuls","year":"2007","journal-title":"Adv Parasitol"},{"issue":"8","key":"10.1016\/j.det.2015.03.018_bib16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"10.1016\/j.det.2015.03.018_bib17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jaad.2009.03.004","article-title":"Tropical dermatology: tropical diseases caused by protozoa","volume":"60","author":"Lupi","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2015.03.018_bib18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(06)70492-3","article-title":"New world cutaneous leishmaniasis in travellers","volume":"6","author":"Schwartz","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.det.2015.03.018_bib19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jac\/dkh058","article-title":"Treatment of cutaneous leishmaniasis among travellers","volume":"53","author":"Blum","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.det.2015.03.018_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00281-012-0350-8","article-title":"Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis","volume":"34","author":"Soong","year":"2012","journal-title":"Semin Immunopathol"},{"issue":"12","key":"10.1016\/j.det.2015.03.018_bib21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/pim.12007","article-title":"Tissue damage and immunity in cutaneous leishmaniasis","volume":"34","author":"Nylen","year":"2012","journal-title":"Parasite Immunol"},{"issue":"6","key":"10.1016\/j.det.2015.03.018_bib22","first-page":"238","article-title":"Immune response to Leishmania infection","volume":"119","author":"Awasthi","year":"2004","journal-title":"Indian J Med Res"},{"issue":"10","key":"10.1016\/j.det.2015.03.018_bib23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1046\/j.1365-4362.2003.02015.x","article-title":"Rare variants of cutaneous leishmaniasis: whitlow, paronychia, and sporotrichoid","volume":"42","author":"Iftikhar","year":"2003","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2015.03.018_bib24","first-page":"458","article-title":"Erysipeloid leishmaniasis: an unusual clinical presentation","volume":"9","author":"Salmanpour","year":"1999","journal-title":"Eur J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2015.03.018_bib25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1365-2133.1997.tb03676.x","article-title":"Leishmaniasis presenting as a psoriasiform eruption in AIDS","volume":"136","author":"Rubio","year":"1997","journal-title":"Br J Dermatol"},{"issue":"Suppl 2","key":"10.1016\/j.det.2015.03.018_bib26","doi-asserted-by":"crossref","first-page":"i60","DOI":"10.1136\/annrheumdis-2011-200596","article-title":"Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats","volume":"71","author":"Bogdan","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.det.2015.03.018_bib27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","article-title":"The relationship between leishmaniasis and AIDS: the second 10 years","volume":"21","author":"Alvar","year":"2008","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.det.2015.03.018_bib28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3201\/eid1506.090101","article-title":"Leishmaniasis, autoimmune rheumatic disease, and anti-tumor necrosis factor therapy, Europe","volume":"15","author":"Xynos","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.det.2015.03.018_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(08)70043-4","article-title":"Leishmaniasis among organ transplant recipients","volume":"8","author":"Antinori","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.det.2015.03.018_bib30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4269\/ajtmh.2012.11-0378","article-title":"Epidemiological and clinical changes in American tegumentary leishmaniasis in an area of Leishmania (Viannia) braziliensis transmission over a 20-year period","volume":"86","author":"Jirmanus","year":"2012","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.det.2015.03.018_bib31","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1708-8305.2009.00341.x","article-title":"Imported leishmaniasis: a heterogeneous group of diseases","volume":"16","author":"Perez-Ayala","year":"2009","journal-title":"J\u00a0Travel Med"},{"issue":"1","key":"10.1016\/j.det.2015.03.018_bib32","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trstmh.2003.08.001","article-title":"Risk factors for mucosal manifestation of American cutaneous leishmaniasis","volume":"99","author":"Machado-Coelho","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.det.2015.03.018_bib33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0198-8859(91)90088-Q","article-title":"Association of mucosal leishmaniasis with HLA","volume":"32","author":"Petzl-Erler","year":"1991","journal-title":"Hum Immunol"},{"issue":"5","key":"10.1016\/j.det.2015.03.018_bib34","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/317455","article-title":"Visceral leishmaniasis during childhood in southern Greece","volume":"31","author":"Maltezou","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.det.2015.03.018_bib35","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/clind\/24.4.684","article-title":"Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years","volume":"24","author":"Berman","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.det.2015.03.018_bib36","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/qjmed\/92.11.659","article-title":"Out-patient parenteral antimicrobial therapy: a viable option for the management of cutaneous leishmaniasis","volume":"92","author":"Seaton","year":"1999","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.det.2015.03.018_bib37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4269\/ajtmh.1987.36.489","article-title":"Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods","volume":"36","author":"Weigle","year":"1987","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.det.2015.03.018_bib38","series-title":"Dermatology","first-page":"1391","article-title":"Protozoa and worms: leishmaniasis","author":"Bolognia","year":"2012"},{"issue":"1","key":"10.1016\/j.det.2015.03.018_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2004.12.003","article-title":"Polymerase chain reaction (PCR) is highly sensitive for diagnosis of mucosal leishmaniasis","volume":"94","author":"Oliveira","year":"2005","journal-title":"Acta Trop"},{"issue":"4","key":"10.1016\/j.det.2015.03.018_bib40","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0035-9203(93)90030-T","article-title":"The clinical and immunological spectrum of American cutaneous leishmaniasis","volume":"87","author":"Convit","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.det.2015.03.018_bib41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0035-9203(99)90129-3","article-title":"Evaluation of a standardized leishmanin skin test in Guatemala","volume":"93","author":"Arana","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.det.2015.03.018_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004834.pub2","article-title":"Interventions for American cutaneous and mucocutaneous leishmaniasis","author":"Gonzalez","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.det.2015.03.018_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005067.pub3","article-title":"Interventions for Old World cutaneous leishmaniasis","author":"Gonzalez","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.det.2015.03.018_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1590\/S0074-02762001000200005","article-title":"Clinical picture of cutaneous leishmaniases due to Leishmania (Leishmania) mexicana in the Yucatan peninsula, Mexico","volume":"96","author":"Andrade-Narvaez","year":"2001","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"1","key":"10.1016\/j.det.2015.03.018_bib45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/0022-3859.928","article-title":"Cutaneous leishmaniasis: an overview","volume":"49","author":"Hepburn","year":"2003","journal-title":"J\u00a0Postgrad Med"},{"issue":"9496","key":"10.1016\/j.det.2015.03.018_bib46","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.det.2015.03.018_bib47","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4269\/ajtmh.2012.11-0682","article-title":"Leishmaniasis in the United States: treatment in 2012","volume":"86","author":"Murray","year":"2012","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.det.2015.03.018_bib48","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/157489108786242341","article-title":"Visceral leishmaniasis: advances in treatment","volume":"3","author":"Maltezou","year":"2008","journal-title":"Recent Pat Antiinfect Drug Discov"},{"issue":"4","key":"10.1016\/j.det.2015.03.018_bib49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/00034980120064355","article-title":"Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana","volume":"95","author":"Nacher","year":"2001","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"10.1016\/j.det.2015.03.018_bib50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2005.72.133","article-title":"Comparison of meglumine antimoniate and pentamidine for Peruvian cutaneous leishmaniasis","volume":"72","author":"Andersen","year":"2005","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.det.2015.03.018_bib51","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies","volume":"46","author":"Herwaldt","year":"1992","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.det.2015.03.018_bib52","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1086\/515027","article-title":"Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience","volume":"27","author":"Aronson","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.det.2015.03.018_bib53","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2165\/00003495-199856060-00005","article-title":"Practical guide for the treatment of leishmaniasis","volume":"56","author":"Davidson","year":"1998","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.det.2015.03.018_bib54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0035-9203(92)90427-E","article-title":"Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol","volume":"86","author":"Antezana","year":"1992","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.det.2015.03.018_bib55","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/520665","article-title":"Amphotericin B treatment for Indian visceral leishmaniasis: response to 15 daily versus alternate-day infusions","volume":"45","author":"Sundar","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.det.2015.03.018_bib56","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1473-3099(05)70296-6","article-title":"Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004","volume":"5","author":"Olliaro","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.det.2015.03.018_bib57","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3201\/eid0907.030023","article-title":"Leishmaniasis in Germany","volume":"9","author":"Harms","year":"2003","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.det.2015.03.018_bib58","first-page":"365","article-title":"A\u00a0comparative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20 mg SbV\/day for 20 days to treat cutaneous leishmaniasis","volume":"36","author":"de Paula","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"issue":"3","key":"10.1016\/j.det.2015.03.018_bib59","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/clind\/16.3.417","article-title":"Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia","volume":"16","author":"Soto-Mancipe","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"24","key":"10.1016\/j.det.2015.03.018_bib60","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis","volume":"341","author":"Jha","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.det.2015.03.018_bib61","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/510588","article-title":"Treatment of Bolivian mucosal leishmaniasis with miltefosine","volume":"44","author":"Soto","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.det.2015.03.018_bib62","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/383321","article-title":"Miltefosine for new world cutaneous leishmaniasis","volume":"38","author":"Soto","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.det.2015.03.018_bib63","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2230.2003.01169.x","article-title":"Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate","volume":"28","author":"Faghihi","year":"2003","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.det.2015.03.018_bib64","doi-asserted-by":"crossref","first-page":"466","DOI":"10.4269\/ajtmh.2001.65.466","article-title":"Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala","volume":"65","author":"Arana","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.det.2015.03.018_bib65","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.actatropica.2004.03.009","article-title":"Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis","volume":"91","author":"Armijos","year":"2004","journal-title":"Acta Trop"},{"issue":"12","key":"10.1016\/j.det.2015.03.018_bib66","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major","volume":"346","author":"Alrajhi","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.det.2015.03.018_bib67","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4269\/ajtmh.2007.76.48","article-title":"Healing of Old World cutaneous leishmaniasis in travelers treated with fluconazole: drug effect or spontaneous evolution?","volume":"76","author":"Morizot","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.det.2015.03.018_bib68","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/pde.12321","article-title":"Cutaneous leishmaniasis: treatment with low-dose oral fluconazole with an excellent cosmetic result","volume":"32","author":"Aerts","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.det.2015.03.018_bib69","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/ced.12359","article-title":"Intermediate cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis successfully treated with fluconazole","volume":"39","author":"Daly","year":"2014","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"10.1016\/j.det.2015.03.018_bib70","doi-asserted-by":"crossref","first-page":"e83247","DOI":"10.1371\/journal.pone.0083247","article-title":"In\u00a0vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis","volume":"8","author":"de Macedo-Silva","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.det.2015.03.018_bib71","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.etap.2014.04.003","article-title":"Anti-leishmanial effect of itraconazole niosome on in\u00a0vitro susceptibility of Leishmania tropica","volume":"38","author":"Khazaeli","year":"2014","journal-title":"Environ Toxicol Pharmacol"},{"issue":"4","key":"10.1016\/j.det.2015.03.018_bib72","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1590\/S0036-46652007000400008","article-title":"Low efficacy of azithromycin to treat cutaneous leishmaniasis in Manaus, AM, Brazil","volume":"49","author":"Teixeira","year":"2007","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"1","key":"10.1016\/j.det.2015.03.018_bib73","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4269\/ajtmh.2007.77.99","article-title":"Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis","volume":"77","author":"Layegh","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.det.2015.03.018_bib74","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1590\/S0036-46652004000300011","article-title":"Azithromycin in the treatment of mucosal leishmaniasis","volume":"46","author":"Silva-Vergara","year":"2004","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"6","key":"10.1016\/j.det.2015.03.018_bib75","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/314782","article-title":"Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action","volume":"179","author":"Buates","year":"1999","journal-title":"J\u00a0Infect Dis"},{"issue":"10","key":"10.1016\/j.det.2015.03.018_bib76","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/429238","article-title":"Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru","volume":"40","author":"Miranda-Verastegui","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.det.2015.03.018_bib77","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1086\/518172","article-title":"Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis","volume":"44","author":"Arevalo","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.det.2015.03.018_bib78","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/24.2.165","article-title":"Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate","volume":"24","author":"Martinez","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.det.2015.03.018_bib79","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJM199203123261105","article-title":"Allopurinol in the treatment of American cutaneous leishmaniasis","volume":"326","author":"Martinez","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.det.2015.03.018_bib80","doi-asserted-by":"crossref","first-page":"232","DOI":"10.7326\/0003-4819-126-3-199702010-00010","article-title":"Inefficacy of allopurinol as monotherapy for Colombian cutaneous leishmaniasis. A randomized, controlled trial","volume":"126","author":"Velez","year":"1997","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.det.2015.03.018_bib81","first-page":"353","article-title":"Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran","volume":"81","author":"Asilian","year":"2003","journal-title":"Bull World Health Organ"},{"issue":"5","key":"10.1016\/j.det.2015.03.018_bib82","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2230.2006.02182.x","article-title":"Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial","volume":"31","author":"Asilian","year":"2006","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"10.1016\/j.det.2015.03.018_bib83","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archderm.142.12.1575","article-title":"Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial","volume":"142","author":"Firooz","year":"2006","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.det.2015.03.018_bib84","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.actatropica.2007.05.005","article-title":"Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran","volume":"103","author":"Mohebali","year":"2007","journal-title":"Acta Trop"},{"issue":"8","key":"10.1016\/j.det.2015.03.018_bib85","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1086\/428736","article-title":"Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial","volume":"40","author":"Reithinger","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.det.2015.03.018_bib86","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-4632.2006.02867.x","article-title":"Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis","volume":"45","author":"Sadeghian","year":"2006","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2015.03.018_bib87","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-9343(90)90292-L","article-title":"Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis","volume":"89","author":"Saenz","year":"1990","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.det.2015.03.018_bib88","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4269\/ajtmh.2004.71.577","article-title":"Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis","volume":"71","author":"Soto","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.det.2015.03.018_bib89","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jaad.2007.12.032","article-title":"Efficacy of a weekly cryotherapy regimen to treat Leishmania major cutaneous leishmaniasis","volume":"58","author":"Mosleh","year":"2008","journal-title":"Am J Acad Dermatol"},{"key":"10.1016\/j.det.2015.03.018_bib90","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1365-4362.1997.00188.x","article-title":"Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de janeiro, Brazil - an area of leishmania (V.) braziliensis transmission","volume":"36","author":"Oliveira-Neto","year":"1997","journal-title":"Int J Derm"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863515000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863515000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T18:41:25Z","timestamp":1566931285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863515000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":90,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0733863515000315"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2015.03.018","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New World and Old World Leishmania Infections","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2015.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}